Business · 21/04/2025Updated: 10/17/2026 · 1 min read
FDA Amends Notice for Joint Meeting of Drug Safety and Risk Management Advisory Committee and Anesthetic and Analgesic Drug Products Advisory Committee
Summary
The FDA is updating the notice for a joint meeting of two advisory committees, with no changes to the meeting's content, to reflect changes in the meeting's details.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →